For the Inventor, By the Inventor

Enter assignee name

Washington, DC, United States of America

60 Degrees Pharmaceuticals, LLC

USPTO Granted Patents = 13

Forward Citations = 13

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Geoffrey Stuart Dow (12 out of 14 patents)

Satoru Watanabe (4 out of 6 patents)

Subhash G Vasudevan (4 out of 6 patents)

4. Eng Eong Ooi (4 out of 7 patents)

5. Jenny Low (4 out of 4 patents)

6. Bryan L Smith (4 out of 7 patents)

7. John P Jones (4 out of 4 patents)

8. Moshe Shmuklarsky (4 out of 4 patents)

9. Budda Balasubrahmanyam (4 out of 4 patents)

10. Mark Reid (3 out of 3 patents)

11. Glynn Morrish (3 out of 3 patents)

12. Cynthia Sung (3 out of 3 patents)

13. Abhay Rathore (3 out of 4 patents)

14. Kitti Wing Ki Chan (1 out of 1 patent)

13 patents: Sort by Forward Citations

1. 12691107 - METHODS FOR THE TREATMENT AND PREVENTION OF LUNG INFECTIONS CAUSED BY GRAM-POSITIVE BACTERIA, FUNGUS, OR VIRUS BY ADMINISTRATION OF TAFENOQUINE (2026-07-28),

2. 12673053 - METHODS FOR THE TREATMENT AND PREVENTION OF LUNG INFECTIONS CAUSED BY SARS-COV-2 VIRUS BY ADMINISTRATION OF TAFENOQUINE (2026-07-07),

3. 12616689 - Regimens of tafenoquine for prevention of malaria in malaria-naive subjects (2026-05-05),

4. 12569473 - Methods to treat respiratory infection utilizing castanospermine analogs (2026-03-10),

5. 12383546 - Methods for the treatment and prevention of lung infections caused by fungus by administration of tafenoquine (2025-08-12),

6. 11744828 - Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects (2023-09-05),

7. 11633391 - Methods for the treatment and prevention of lung infections caused by gram-positive bacteria, fungus, or virus by administration of tafenoquine (2023-04-25),

8. 11219616 - Dosing regimens of celgosivir for the treatment of dengue (2022-01-11),

9. 11000516 - Dosing regimens of celgosivir for the prevention of dengue (2021-05-11),

10. 10888558 - Regimens of tafenoquine for prevention of malaria in malaria-naive subjects (2021-01-12),

11. 10517854 - Dosing regiments of celgosivir for the treatment of dengue (2019-12-31),

12. 10342791 - Regimens of tafenoquine for prevention of malaria in malaria-naive subjects (2019-07-09),

13. 9763921 - Dosing regimens of celgosivir for the treatment of dengue (2017-09-19),

Company Overview

60 Degrees Pharmaceuticals, LLC is a biotechnology company based in Washington, DC, specializing in the development of innovative therapeutics for infectious diseases. The organization focuses on addressing unmet medical needs through advanced research and technology, particularly in the areas of drug formulation and delivery systems. By leveraging cutting-edge scientific approaches, 60 Degrees Pharmaceuticals aims to enhance treatment efficacy and improve patient outcomes in global health contexts.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

13 Patents

#64 in Washington, DC

#64 in District of Columbia

#23,815 in US

#44,988 in the World

Washington, DC, United States of America

60 Degrees Pharmaceuticals, LLC

Forward Citations = 13

14 inventors:

Geoffrey Stuart Dow (12 out of 14 patents)

Satoru Watanabe (4 out of 6 patents)

Subhash G Vasudevan (4 out of 6 patents)

4. Eng Eong Ooi (4 out of 7 patents)

5. Jenny Low (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: 60 Degrees Pharmaceuticals, LLC. Retrieved from https://idiyas.com/company/60-degrees-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…